TWI812918B - IL-7Rαγc結合化合物 - Google Patents

IL-7Rαγc結合化合物 Download PDF

Info

Publication number
TWI812918B
TWI812918B TW110104084A TW110104084A TWI812918B TW I812918 B TWI812918 B TW I812918B TW 110104084 A TW110104084 A TW 110104084A TW 110104084 A TW110104084 A TW 110104084A TW I812918 B TWI812918 B TW I812918B
Authority
TW
Taiwan
Prior art keywords
ligand
7rαγc
seq
amino acid
ligands
Prior art date
Application number
TW110104084A
Other languages
English (en)
Chinese (zh)
Other versions
TW202144390A (zh
Inventor
威廉 J 道爾
邁克爾 C 尼德斯
羅納德 W 巴雷特
艾麗絲 V 巴克
史蒂文 E 科維拉
Original Assignee
美商麥地金公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商麥地金公司 filed Critical 美商麥地金公司
Publication of TW202144390A publication Critical patent/TW202144390A/zh
Application granted granted Critical
Publication of TWI812918B publication Critical patent/TWI812918B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW110104084A 2020-02-03 2021-02-03 IL-7Rαγc結合化合物 TWI812918B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062969432P 2020-02-03 2020-02-03
US62/969,432 2020-02-03
US202063041158P 2020-06-19 2020-06-19
US63/041,158 2020-06-19

Publications (2)

Publication Number Publication Date
TW202144390A TW202144390A (zh) 2021-12-01
TWI812918B true TWI812918B (zh) 2023-08-21

Family

ID=77200524

Family Applications (2)

Application Number Title Priority Date Filing Date
TW110104084A TWI812918B (zh) 2020-02-03 2021-02-03 IL-7Rαγc結合化合物
TW112126553A TW202342505A (zh) 2020-02-03 2021-02-03 IL-7Rαγc結合化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW112126553A TW202342505A (zh) 2020-02-03 2021-02-03 IL-7Rαγc結合化合物

Country Status (12)

Country Link
US (2) US11746139B2 (cg-RX-API-DMAC7.html)
EP (1) EP4100427A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023514128A (cg-RX-API-DMAC7.html)
KR (1) KR20220139918A (cg-RX-API-DMAC7.html)
CN (1) CN115315435A (cg-RX-API-DMAC7.html)
AU (2) AU2021217353A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022015002A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166816A1 (cg-RX-API-DMAC7.html)
IL (1) IL295304A (cg-RX-API-DMAC7.html)
MX (1) MX2022009390A (cg-RX-API-DMAC7.html)
TW (2) TWI812918B (cg-RX-API-DMAC7.html)
WO (1) WO2021158623A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210055694A (ko) 2018-08-06 2021-05-17 메디카인 인코포레이티드 Il-2 수용체 결합 화합물
CA3160466A1 (en) 2019-11-05 2021-05-14 Medikine, Inc. Dual il-2r and il-7r binding compounds
MX2022005411A (es) 2019-11-05 2022-08-10 Medikine Inc COMPUESTOS DE UNIÓN A IL-2RßYC.
US11746139B2 (en) * 2020-02-03 2023-09-05 Medikine, Inc. IL-7Rαγc binding compounds
AU2021217959A1 (en) * 2020-02-03 2022-08-18 Medikine, Inc. IL-7Rα binding compounds
EP4240394A4 (en) * 2020-11-04 2024-10-23 Medikine, Inc. IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF
US20250082777A1 (en) 2022-01-10 2025-03-13 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2023193015A1 (en) 2022-04-01 2023-10-05 Sana Biotechnology, Inc. Cytokine receptor agonist and viral vector combination therapies
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
US20240101959A1 (en) 2022-09-06 2024-03-28 Medikine, Inc. Use of il-2r-beta-gamma agonist peptides in cell manufacturing
US20240100159A1 (en) 2022-09-06 2024-03-28 Medikine, Inc. Use of il-7r-alpha-gamma agonist peptides in cell manufacturing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130330296A1 (en) * 2010-12-10 2013-12-12 University Of Central Florida Research Foundation, Inc. Methods and Compositions Comprising IL-7 Receptor Ligands
TW201713699A (zh) * 2015-08-06 2017-04-16 新加坡科技研究局 介白素2受體β(IL2Rβ)/共同γ鏈抗體
TW201833137A (zh) * 2016-12-09 2018-09-16 法商Ose免疫療法公司 靶向cd127之抗體和多肽

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635597A (en) 1994-05-27 1997-06-03 Affymax Technologies, N.V. Peptides that bind IL-2 receptors
EP1454138B1 (en) 2001-12-04 2012-01-18 Merck Patent GmbH Immunocytokines with modulated selectivity
US20050054054A1 (en) * 2002-11-12 2005-03-10 Foss Francine M. Interleukin-7 molecules with altered biological properties
KR101163424B1 (ko) 2003-12-30 2012-07-13 메르크 파텐트 게엠베하 Il-7 융합 단백질
CN101072793B (zh) 2004-12-09 2012-06-20 默克专利有限公司 具有降低的免疫原性的il-7变体
EP1828231A2 (en) 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus
US20120210458A9 (en) 2009-02-27 2012-08-16 Yongwei Cao Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof
ES2866674T3 (es) 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
CA2824515C (en) 2011-01-18 2022-09-13 Bioniz, Llc Compositions and methods for modulating gamma-c-cytokine activity
JP6592505B2 (ja) 2014-04-24 2019-10-16 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー インターロイキン−2のスーパーアンタゴニスト、パーシャルアゴニスト及びアンタゴニスト
KR102493543B1 (ko) 2014-07-21 2023-01-30 데리니아, 인크. 자가면역 질환의 치료를 위한 조절 t 세포를 선택적으로 활성화시키는 분자
JP6640834B2 (ja) 2014-08-11 2020-02-05 デリニア, インコーポレイテッド 自己免疫疾患の処置のために調節性t細胞を選択的に活性化させる改変il−2変異体
KR102908806B1 (ko) 2015-10-22 2026-01-07 주노 테라퓨틱스 게엠베하 세포의 배양 방법 및 이를 위한 키트와 장치
US20170204154A1 (en) 2016-01-20 2017-07-20 Delinia, Inc. Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
US11053293B2 (en) 2016-02-05 2021-07-06 Washington University Compositions and methods for targeted cytokine delivery
EP3538548A4 (en) 2016-11-08 2020-08-19 Delinia, Inc. IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CN110177564A (zh) 2016-12-13 2019-08-27 德里尼亚公司 多价的调节t细胞调节剂
KR20210055694A (ko) 2018-08-06 2021-05-17 메디카인 인코포레이티드 Il-2 수용체 결합 화합물
WO2020247388A2 (en) 2019-06-03 2020-12-10 Medikine, Inc. Il-2alpha receptor subunit binding compounds
MX2022005411A (es) 2019-11-05 2022-08-10 Medikine Inc COMPUESTOS DE UNIÓN A IL-2RßYC.
US20220119492A1 (en) 2019-11-05 2022-04-21 Medikine, Inc. Il-2r-beta-gamma binding compounds and uses thereof
CA3160466A1 (en) 2019-11-05 2021-05-14 Medikine, Inc. Dual il-2r and il-7r binding compounds
TW202136287A (zh) 2019-12-17 2021-10-01 法商Ose免疫治療公司 包含il-7變體之雙官能分子
AU2021217959A1 (en) 2020-02-03 2022-08-18 Medikine, Inc. IL-7Rα binding compounds
US11746139B2 (en) 2020-02-03 2023-09-05 Medikine, Inc. IL-7Rαγc binding compounds
EP4240394A4 (en) 2020-11-04 2024-10-23 Medikine, Inc. IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130330296A1 (en) * 2010-12-10 2013-12-12 University Of Central Florida Research Foundation, Inc. Methods and Compositions Comprising IL-7 Receptor Ligands
TW201713699A (zh) * 2015-08-06 2017-04-16 新加坡科技研究局 介白素2受體β(IL2Rβ)/共同γ鏈抗體
TW201833137A (zh) * 2016-12-09 2018-09-16 法商Ose免疫療法公司 靶向cd127之抗體和多肽

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
網路文獻 Carmen Burtea et al, "Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium", Arthritis Res Ther. 2016 Oct 12;18(1):230. *

Also Published As

Publication number Publication date
KR20220139918A (ko) 2022-10-17
MX2022009390A (es) 2022-11-16
US20230357358A1 (en) 2023-11-09
TW202342505A (zh) 2023-11-01
AU2021217353A1 (en) 2022-08-25
CN115315435A (zh) 2022-11-08
CA3166816A1 (en) 2021-08-12
IL295304A (en) 2022-10-01
JP2023514128A (ja) 2023-04-05
WO2021158623A1 (en) 2021-08-12
EP4100427A4 (en) 2024-01-17
US11746139B2 (en) 2023-09-05
AU2024201860A1 (en) 2024-05-16
US11965015B2 (en) 2024-04-23
TW202144390A (zh) 2021-12-01
US20210253670A1 (en) 2021-08-19
BR112022015002A2 (pt) 2022-12-06
EP4100427A1 (en) 2022-12-14

Similar Documents

Publication Publication Date Title
US11965015B2 (en) IL-7R-α-γ binding compounds
TWI823054B (zh) IL-7Rα結合化合物
US11248030B2 (en) Dual IL-2R and IL-7R binding compounds
US20230331801A1 (en) Il-2r-beta-gamma binding compounds
EP4268901A2 (en) Il-2r beta-gamma c binding compounds and uses thereof
US20220119492A1 (en) Il-2r-beta-gamma binding compounds and uses thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees